{Reference Type}: Case Reports
{Title}: Crizotinib-associated renal cyst development may be associated with prolonged progression-free survival in patients with ALK-positive non-small-cell lung cancer: Case report and review of the literature.
{Author}: Wiest NE;Tzou KS;Olson MT;Herchko SM;Bajalia EM;Thiel DD;Lou Y;Zhao Y;Manochakian R;
{Journal}: Clin Case Rep
{Volume}: 9
{Issue}: 6
{Year}: Jun 2021
暂无{DOI}: 10.1002/ccr3.4278
{Abstract}: Non-small cell lung cancer patients with anaplastic lymphoma kinase or c-ros oncogene 1 mutations who are treated with the tyrosine kinase inhibitor crizotinib rarely develop crizotinib-associated renal cysts (CARCs). Here, we present a case report and review of the literature supporting the hypothesis that CARCs may correlate positively with progression-free survival.